Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Net Margin (2021 - 2025)

Lucid Diagnostics' Net Margin history spans 5 years, with the latest figure at 1084.4% for Q4 2025.

  • For Q4 2025, Net Margin fell 12024.0% year-over-year to 1084.4%; the TTM value through Dec 2025 reached 1492.2%, down 27211.0%, while the annual FY2025 figure was 1501.47%, 28138.0% down from the prior year.
  • Net Margin reached 1084.4% in Q4 2025 per LUCD's latest filing, down from 866.42% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 4192.52% in Q2 2021 to a low of 18880.26% in Q3 2022.
  • Average Net Margin over 5 years is 3740.24%, with a median of 1811.78% recorded in 2023.
  • Peak YoY movement for Net Margin: tumbled -1540176bps in 2022, then skyrocketed 1706570bps in 2023.
  • A 5-year view of Net Margin shows it stood at 3768.67% in 2021, then plummeted by -254bps to 13328.57% in 2022, then surged by 92bps to 1041.35% in 2023, then rose by 7bps to 964.16% in 2024, then decreased by -12bps to 1084.4% in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Net Margin are 1084.4% (Q4 2025), 866.42% (Q3 2025), and 657.33% (Q2 2025).